Zealand Pink Sheet Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Zealand Pharma's historical fundamentals, such as revenue growth or operating cash flow patterns.
Zealand
Zealand Pharma AS has current Daily Balance Of Power of 9.2 T. Balance of Power indicator (or BOP) measures the strength of Zealand Pharma AS market sensitivity to bulls and bears. It estimates the ability of Zealand Pharma buyers and sellers to push price to an extreme high or extreme low level. As a result, by monitoring Zealand Pharma Balance of Power indicator one can determine a trend of the price direction.
On November 25 2024 Zealand Pharma AS was traded for 104.20 at the closing time. The highest daily price throughout the period was 104.20 and the lowest price was 104.20 . The daily volume was 168. The net trading volume on 11/25/2024 had no short-term effect on price fluctuation. The trading date delta to current closing price is 0.00% .
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
For every potential investor in Zealand, whether a beginner or expert, Zealand Pharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Zealand Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Zealand. Basic forecasting techniques help filter out the noise by identifying Zealand Pharma's price trends.
Zealand Pharma AS Technical and Predictive Analytics
The pink sheet market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Zealand Pharma's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Zealand Pharma's current price.
Market strength indicators help investors to evaluate how Zealand Pharma pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Zealand Pharma shares will generate the highest return on investment. By undertsting and applying Zealand Pharma pink sheet market strength indicators, traders can identify Zealand Pharma AS entry and exit signals to maximize returns.
The analysis of Zealand Pharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Zealand Pharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting zealand pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Other Information on Investing in Zealand Pink Sheet
Zealand Pharma financial ratios help investors to determine whether Zealand Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Zealand with respect to the benefits of owning Zealand Pharma security.